Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Drug Safety|February 22, 2011
A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancerGiannis Mountzios, Kostas N SyrigosBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 10, 2009
Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapiesGeorgios S Papaetis, Kostas N SyrigosCancer Metastasis Reviews|January 30, 2010
Targeted therapy for gastrointestinal stromal tumors: current status and future perspectivesGeorgios S Papaetis, Kostas N SyrigosPathology Research International|July 26, 2011
From the bench to bedside: biological and methodology considerations for the future of companion diagnostics in nonsmall cell lung cancerAnastasios Dimou, Kevin Harrington, Kostas N SyrigosJOP : Journal of the Pancreas|July 9, 2011
Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011Nektaria Makrilia, Kostas N Syrigos, Muhammad W SaifWorld Journal of Gastroenterology|August 13, 2009
Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosisAnastasios Dimou, Kostas N Syrigos, Muhammad Wasif SaifJOP : Journal of the Pancreas|July 31, 2014
Quality of life in patients with pancreatic cancerMaria Kiagia, Kostas N Syrigos, Muhammad Wasif SaifJOP : Journal of the Pancreas|July 13, 2013
Update on novel therapies for pancreatic neuroendocrine tumors: 2013Anastasios Dimou, Kostas N Syrigos, Muhammad Wasif SaifCancer Treatment Reviews|January 29, 2010
Targeted therapeutic approaches for hormone-refractory prostate cancerFlora Stavridi, Eleni M Karapanagiotou, Kostas N SyrigosJournal of Nutrition and Metabolism|January 29, 2011
Role of vitamin d in the prevention of pancreatic cancerPubudu Bulathsinghala, Kostas N Syrigos, Muhammad W SaifPageof 8